A USA-based VC firm builds and invests in companies in the healthcare sector, with a focus on personalized health and consumer health. The firm typically invests in seed or Series A rounds and initial investments range from $150,000-$1.5 million, with a potential commitment of up to $5 million over the life of the investment. The firm invests in the USA and Canada.
The firm focuses on healthtech and tech-enabled health services. The firm is interested in disease management (includes chronic, autoimmune, mental/behavioral, neurology, microbiome, and digital therapeutics), care management, precision medicine, remote monitoring (including pushing the point of care into ambulatory settings such as retail clinics and the home), population health management (including underserved patients and Medicaid recipients, and patients living in areas outside the East Coast and West Coast). The firm is also open to investing in devices and diagnostics, but only if they are targeted at consumers/patients as users, rather than physicians.
The firm generally does not invest in companies that face FDA regulatory risk; the firm invests in companies with products that are already approved or do not require FDA approval. The firm prefers to invest in revenue generating companies but will consider startups that will begin to generate revenue in 6-12 months.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment